The effects of a diabetes pre-consultation booklet for patients with type 2 diabetes on patients’ and doctors’ communication during the consultation and on patient outcomes.

ISRCTN ISRCTN12822620
DOI https://doi.org/10.1186/ISRCTN12822620
Secondary identifying numbers N/A
Submission date
14/02/2012
Registration date
13/03/2012
Last edited
21/01/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
It is important that patients are given the opportunity to be involved in their diabetes care. Good communication between the doctor and the patient can help patients be more involved. The aim of our study is to explore if a pre-consultation booklet for people with type 2 diabetes can help patients and diabetes hospital doctors communicate better in the consultation and improve patient outcomes. The pre-consultation intervention booklet will encourage people to ask questions and provide them with their own personal clinical data and examples of questions they might like to ask during the consultation.

Who can participate?
People with type 2 diabetes aged 75 or under who are attending general diabetes outpatient clinics at the Diabetes Day Centre at the University Hospital Galway for review appointments will be approached to participate in the study.

What does the study involve?
Participants will be randomly allocated to one of three groups. The first group will receive an intervention booklet (containing personalised clinical information and prompt questions) at least 48 hours before their review appointment. The second group will receive a general information booklet (containing a glossary of diabetes topics usually discussed during a review visit) at least 48 hours before their review appointment. The third group will not receive a booklet. Those participating in the study will need to attend the Diabetes Day Centre 1-4 weeks before their review clinic appointment to have their HbA1c, cholesterol, blood pressure and Body Mass Index measured.
Participants will complete short questionnaires on a number of occasions including when they have their blood tests done at the beginning of the project, directly before and after their first and second review appointment, six weeks after their first and second appointment, and six months after their second review visit. Data from patients in the control, general information, and intervention groups will be compared to see if there are any differences in patient outcomes and in how patients and doctors communicate during the consultation.

What are the possible benefits and risks of participating?
Findings from our research study may help improve the way we deliver diabetes care in the future.

Where is the study run from?
The Diabetes Day Centre, University Hospitals Galway (Ireland).

When is study starting and how long is it expected to run for?
The study ran from January 2011 to January 2014.

Who is funding the study?
This project is funded by the Health Research Board (HRB) (Ireland).

Who is the main contact?
Dr Máire O Donnell
maire.odonnell@nuigalway.ie

Contact information

Dr Sean Dinneen
Scientific

Clinical Science Institute
National University of Ireland Galway
University Road
Galway
-
Ireland

Phone +353 91 495290
Email sean.dinneen@nuigalway.ie

Study information

Study designExploratory randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleDevelopment and assessment of the feasibility, acceptability and potential effectiveness of a Patient Information Pre-consultation Package containing personalised clinical information for patients with type 2 diabetes attending an outpatient diabetes clinic for a review visit: a mixed methods approach (PIPP study)
Study acronymPIPP
Study objectivesThe aim of this study is to design and evaluate a patient intervention to be given to type 2 diabetes patients prior to their outpatient review visit in order to facilitate their involvement in the consultation and to explore the effects of this information on clinical and psychosocial outcomes.

Specific objectives:
1. To develop a personalised clinical information sheet for patients with Type 2 diabetes informing them of the current status of their diabetes
2. To compare the administration of this personalised clinical information sheet during diabetes clinic attendance with administration of a non-personalised information sheet and with no administration (i.e. routine care)
3. To explore the feasibility of a large multi-centre trial evaluating this approach to diabetes care delivery in other diabetes clinics in Ireland
Ethics approval(s)1. Galway Regional Hospitals Research Ethics Committee, December 2010, ref: 11 January 2010
2. National University of Ireland Galway Research Ethics Committee, March 2011, ref: C.A.507
Health condition(s) or problem(s) studiedType 2 diabetes
InterventionThe intervention is a pre-consultation booklet that the intervention group will receive at least 48 hours before their review appointment. The intervention booklet will include personalised diabetes-related clinical information about their weight, body mass index, blood pressure and recent laboratory results including HbA1c and cholesterol levels. They will also receive prompt questions relating to their their personal clinical information and diabetes care. They will receive this intervention on two occasions at two consecutive clinic visits.
Intervention typeOther
Primary outcome measure1. HbA1c
2. Measure of diabetes self-efficacy
Secondary outcome measures1. Patient anxiety
2. Patient satisfaction with the consultation
3. Weight
4. Cholesterol
5. Blood pressure
6. Self-care activities
7. Diabetes-related distress
Overall study start date05/01/2011
Completion date04/01/2014

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants150 patients
Key inclusion criteria1. People with type 2 diabetes of at least 12 months duration
2. People with type 2 diabetes attending general diabetes outpatient clinics
3. People with type 2 who have had their blood tests done (HbA1c, lipids) within 8 weeks of recruitment into the study
Key exclusion criteria1. People with Type 1 diabetes
2. People with type 2 diabetes whose English language ability, literacy or cognitive function will not enable them to participate in the study
3. People with type 2 diabetes who have not had blood tests (HbA1c, lipids) done within 8 weeks of their outpatient visit
Date of first enrolment05/01/2011
Date of final enrolment04/01/2014

Locations

Countries of recruitment

  • Ireland

Study participating centre

Clinical Science Institute
Galway
-
Ireland

Sponsor information

Health Research Board (Ireland)
Government

73 Lower Baggot Street
Dublin
2
Ireland

Phone +353 1 234 5000
Email hrb@hrb.ie
Website http://www.hrb.ie/
ROR logo "ROR" https://ror.org/003hb2249

Funders

Funder type

Government

Health Research Board (Ireland), ref: HRA_HSR/2010/19
Private sector organisation / Other non-profit organizations
Alternative name(s)
HRB
Location
Ireland

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2016 21/01/2019 Yes No

Editorial Notes

21/01/2019: publication reference added